Medigen Vaccine Biologics Corp.
Registry sponsor category
Industry
- Other names
- Medigen Vaccine Biologics Corp.
- Company name
- Medigen Vaccine Biologics Corp.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Website
- https://www.medigenvac.com/
- Publicly traded (proxy)
- No
- Listing at source
- Listed
- Wikidata ID
- Q101251708
Related records
Trials (21)
- A Clinical Study for Inactivated Vaccine Against EV71
- A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan
- A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19
- A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study
- A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults
- A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above
- A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222
- A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents
- A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult
- A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine
- A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years
- A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19
- A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects
- A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19
- A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19
- Long-Term Immunogenicity of Envacgen® in Children
- Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children